Technosphere insulin provides better early postprandial glucose control than s.c. rapid-acting analogue

被引：0
|
作者：
Grant, M. [1 ]
Pompilio, F. [1 ]
Sharma, G. [1 ]
Zaveri, N. [1 ]
Krueger, J. [1 ]
Kendall, D. [1 ]
机构：
[1] MannKind Corp, Westlake Village, CA USA
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
183
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 26 条
  • [1] TECHNOSPHERE INSULIN PROVIDES BETTER EARLY POSTPRANDIAL GLUCOSE CONTROL THAN SUBCUTANEOUS RAPID-ACTING ANALOGUE
    Grant, M.
    Pompilio, F.
    Sharma, G.
    Zaveri, N.
    Krueger, J.
    Kendall, D.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A44 - A45
  • [2] Technosphere Insulin Provides Better Early Postprandial Glucose Control than Subcutaneous Rapid-Acting Analog
    Grant, Marshall L.
    Pompilio, Frank
    Sharma, Gaurav
    Krueger, John A.
    Kendall, David M.
    Zaveri, Nadia
    [J]. DIABETES, 2019, 68
  • [3] Technosphere insulin suppresses endogenous glucose production earlier than a rapid-acting analogue (lispro) and an inhaled insulin (Exubera®)
    Potocka, E.
    Hovorka, R.
    Baughman, R.
    Umpleby, M.
    Diaz, M.
    Chen, R.
    Cassidy, J.
    Boss, A.
    Richardson, P.
    [J]. DIABETOLOGIA, 2009, 52 : S374 - S374
  • [4] Postprandial administration of the rapid-acting insulin analogue insulin aspart in type 1 diabetic patients
    Brunner, GA
    Hirschberger, S
    Sendlhofer, G
    Wutte, A
    Ellmerer, M
    Schaupp, L
    Pieber, TR
    [J]. DIABETOLOGIA, 1999, 42 : A238 - A238
  • [5] Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients With Diabetes
    Engwerda, Elsemiek E. C.
    Tack, Cees J.
    de Galan, Bastiaan E.
    [J]. DIABETES CARE, 2013, 36 (11) : 3436 - 3441
  • [6] Effects of the rapid-acting insulin analogue Insulin Aspart on postprandial glycaemic excursions in type 2 diabetes
    Thorsby, P
    Rosenfalck, AM
    Kjems, L
    Hanssen, KF
    Madsbad, S
    Birkeland, KI
    [J]. DIABETOLOGIA, 1999, 42 : A17 - A17
  • [7] Significantly improved postprandial glycaemic control with the novel rapid-acting insulin aspart
    Lindholm, A
    McEwen, J
    Riis, A
    [J]. DIABETOLOGIA, 1998, 41 : A49 - A49
  • [8] The effect of preprandial vs. postprandial administration of rapid-acting insulin analogue on continuous glucose monitoring in type 1 diabetic patients
    Gelber, A.
    Liberty, I. F.
    Perry, Z. H.
    Botach, E.
    Harman-Boehm, I.
    [J]. DIABETOLOGIA, 2008, 51 : S436 - S437
  • [9] The use of rapid-acting insulin analogue as the baseline infusion during glucose clamping improves pharmacokinetic evaluation
    Cassidy, J.
    Baughman, R.
    Tonelli, G.
    Boss, A.
    Hernandez, B.
    Schwartz, S.
    [J]. DIABETOLOGIA, 2007, 50 : S396 - S396
  • [10] A 3 month comparison in type 1 diabetes of inhaled Technosphere®/Insulin (TI) to sc administered rapid-acting insulin analogue (RAA) as prandial insulin in a basal/prandial regimen
    Boss, Anders H.
    Baughman, Robert A.
    Evans, Shawna H.
    Firsov, Igor
    Kramer, David A.
    Richardson, Peter
    [J]. DIABETES, 2006, 55 : A97 - A97
123